Opus Genetics annual operating margin
2019
2021
2022
2023
2024
2025
Opus Genetics's operating margin was −271.90% for fiscal 2025.
View full Opus Genetics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −271.90% | +292.82 pp |
| 2024 | 2024-12-31 | −564.72% | −509.27 pp |
| 2023 | 2023-12-31 | −55.45% | −101.19 pp |
| 2022 | 2022-12-31 | 45.74% | +3900.58 pp |
| 2021 | 2021-12-31 | −3,854.84% | −3715.07 pp |
| 2019 | 2019-12-31 | −139.77% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −2,182.78% | −1873.76 pp |
| Q1 2026 | 2026-03-31 | −665.92% | −438.72 pp |
| Q4 2025 | 2025-12-31 | −296.33% | +587.66 pp |
| Q3 2025 | 2025-09-30 | −269.93% | −62.81 pp |
| Q2 2025 | 2025-06-30 | −309.02% | +439.90 pp |
| Q1 2025 | 2025-03-31 | −227.21% | +223.29 pp |
| Q4 2024 | 2024-12-31 | −883.98% | −562.93 pp |
| Q3 2024 | 2024-09-30 | −207.11% | −260.62 pp |
| Q2 2024 | 2024-06-30 | −748.92% | −602.24 pp |
| Q1 2024 | 2024-03-31 | −450.50% | −99.95 pp |
| Q4 2023 | 2023-12-31 | −321.05% | −406.90 pp |
| Q3 2023 | 2023-09-30 | 53.51% | +918.95 pp |
| Q2 2023 | 2023-06-30 | −146.68% | +6990.32 pp |
| Q1 2023 | 2023-03-31 | −350.54% | −112.72 pp |
| Q4 2022 | 2022-12-31 | 85.85% | +217.11 pp |
| Q3 2021 | 2021-09-30 | −865.44% | +16142.63 pp |
| Q2 2021 | 2021-06-30 | −7,137.00% | — |
| Q1 2020 | 2020-03-31 | −237.83% | — |
| Q1 2019 | 2019-03-31 | −131.26% | — |
| Q2 2010 | 2010-06-30 | −17,008.07% | — |
Over the last five reported fiscal years, Opus Genetics's operating margin decreased from −139.77% to −271.90%, a change of −132.13 percentage points. The latest reported quarter, Q2 2026, shows −2,182.78%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Opus Genetics filings at SEC.gov ↗